6月2日，Oscar Health盘中下跌5.09%，报21.905美元/股，成交额4468.8万美元。
消息面上，公司首席技术官兼联合创始人Mario Schlosser正式卸任CTO职务，转为联合创始人及CEO顾问角色，但将继续留任公司董事会。作为一家以全栈技术平台为核心竞争力的医疗保健科技公司，CTO的离任引发市场对公司技术战略连续性的担忧。Oscar Health围绕技术驱动的会员体验和数据AI平台构建差异化优势，核心技术高管的角色变动对投资者信心形成短期冲击。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.